Veracyte (VCYT) Reports Publication Validating Clinical Utility of Veracyte s Decipher Prostate Genomic Classifier streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Oncology drug costs overall, and immunotherapy costs specifically, drove Medicare spending increases for outpatient end-of-life cancer care, according to research in International Journal of Radiation Oncology, Biology, Physics.Expanding use of biosimilars may be an effective approach to moderate cancer drug costs, researchers concluded.
Immunotherapy Costs Drive Increase in Medicare Spending for Outpatient Cancer Care at the End of Life itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.
Men diagnosed with prostate cancer can benefit from “radical radiotherapy” that delivers treatment in five hospital visits instead of the typical 20, according to the results of a clinical trial led by Queen’s University Belfast.